SERPLULIMAB vs SIPONIMOD: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SERPLULIMAB vs SIPONIMOD: Safety Overview
| Metric | SERPLULIMAB | SIPONIMOD |
|---|---|---|
| Total FAERS Reports | 137 | 8,581 |
| Deaths Reported | 36 | 196 |
| Death Rate | 26.3% | 2.3% |
| Hospitalizations | 81 | 1,396 |
| Average Patient Age | 63.0 yrs | 53.8 yrs |
| % Female Patients | 11.1% | 74.4% |
| FDA Approval Date | N/A | Apr 22, 2025 |
| Manufacturer | N/A | Novartis Pharmaceuticals Corporation |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |